Transcript

. What is Pharmacovigilance?

Pharmacovigilance is the science of collecting, monitoring, researching, assessing and
evaluating information from healthcare providers and patients on the adverse effects of
medications, biological products, herbalism and traditional medicines.
2. What is the minimum criterion required for a valid case?
a. An identifiable reporter
b. An identifiable patient
c. A suspect product
d. An adverse drug event
3. What is an Adverse Drug Event (ADE)?
Any untoward medical occurrence in a patient or clinical investigation subject administered a
pharmaceutical product and which does not necessarily have to have a causal relationship with
this treatment.
4. What is an Adverse Drug Reaction (ADR)?
An adverse drug reaction is a “response to a drug which is noxious and unintended and which
occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of disease or for
the modification of physiologic function.” Note that there is a causal link between a drug and
an adverse drug reaction. In sum, an adverse drug reaction is harm directly caused by the drug
at normal doses, during normal use.
5. What is the difference between an ADE and ADR?
There may not be a causal relationship between a drug and an ADE, whereas, there is a causal
link between a drug and an adverse drug reaction.
6. When do you consider an event to be serious?
If an event is associated with any one of the following, it is considered to be serious
a. Death
b. Life threatening
c. Hospitalization or prolongation of hospitalization.
d. Congenital anomaly
e. Disability
f. Medically significant
7. Name the regulatory bodies in USA, UK, Japan and India?
USA: United States Food and drug administration (USFDA).
UK: European Medicines Agency (EMEA).
Japan: Ministry of Health, Labour and Welfare (MHLW).
India: Central Drugs Standard Control Organization (CDSCO)
8. What is Volume 9A?
Volume 9A brings together general guidance on the requirements, procedures, roles and
activities in the field of pharmacovigilance, for both Marketing Authorisation Holders (MAH)
and Competent Authorities of medicinal products for human use; it incorporates international
agreements reached within the framework of the International Conference on Harmonisation
(ICH).
Volume 9A is presented in four parts:
Part I deals with Guidelines for Marketing Authorisation Holders;
Part II deals with Guidelines for Competent Authorities and the Agency;
Part III provides the Guidelines for the electronic exchange of pharmacovigilance in the EU
Part IV provides Guidelines on pharmacovigilance communication.

Regulatory Interventions. question on phaarmacovigilance in interview. iso 8859 1. When do you consider a case to be medically confirmed? A case is considered to be medically confirmed if it contains at least one event confirmed or reported by an HCP (Health Care Professional) Note: HCP can be a physician. http colleged info find pharmacovigilance interview questions and answers for freshers pdf. In Pharmacovigilance. What are the types of Pharmacovigilance (PV)? A.Passive PV Active PV: Active (or proactive) safety surveillance means that active measures are taken to detect adverse events. This is the most common form of pharmacovigilance. The most comprehensive method is cohort event monitoring (CEM) Passive PV: Passive surveillance means that no active measures are taken to look for adverse effects other than the encouragement of health professionals and others to report safety concerns. pdf pharmacovigillance . coroner or psychologist (only in Germany). Q. What are Data assessments in Pharmacovigilance? A. It is commonly referred to as “spontaneous” or “voluntary” reporting. What are the objectives in Pharmacovigilance? A. This is managed by active follow-up after treatment and the events may be detected by asking patients directly or screening patient records. Q. 1. Reporting is dependent on the initiative and motivation of the potential reporters. What do you mean by causality? Causality is the relationship between a set of factors. Safety reporting due dates are 7days for IND Reporting and 15 days for NDA Reporting Q. ADR Monitoring schemes. Data assessments are Individual case report assessment Aggregated assessment and interpretation Signal detection Interactions and risk factors Serial study Frequency Estimation Find Reply Quote Enter Keyw ords « Next Oldest | Next Newest » New Reply Marked Tags: pharmacovigilance for freshers. Active PV and 2. Two types. nurse. causality is the relationship between the suspect product and the adverse drug event. What are the due dates for safety reporting? A. Q. Medical Errors. Public Health Significance. interview questions for pharmacovigilance job pdf. 10. Understanding the concepts of ADR. pharmacist.9.

ms android sonymobile. pharmacovigilance interview questions and answers pdf. android unknown. ms android samsung. 615654. pharmacovigilance interview questions for freshers.interview. android launcher search. pharmacovigilance interview questions and answers. webhp. . pharmacovigilance fresher interview pdf. pharmacovigilance fresher question for interview.